1
|
Adams DQ, Alduino C, Alfonso K, Avignone FT, Azzolini O, Bari G, Bellini F, Benato G, Beretta M, Biassoni M, Branca A, Brofferio C, Bucci C, Camilleri J, Caminata A, Campani A, Canonica L, Cao XG, Capelli S, Capelli C, Cappelli L, Cardani L, Carniti P, Casali N, Celi E, Chiesa D, Clemenza M, Copello S, Cremonesi O, Creswick RJ, D'Addabbo A, Dafinei I, Del Corso F, Dell'Oro S, Di Domizio S, Di Lorenzo S, Dompè V, Fang DQ, Fantini G, Faverzani M, Ferri E, Ferroni F, Fiorini E, Franceschi MA, Freedman SJ, Fu SH, Fujikawa BK, Ghislandi S, Giachero A, Gianvecchio A, Gironi L, Giuliani A, Gorla P, Gotti C, Gutierrez TD, Han K, Hansen EV, Heeger KM, Huang RG, Huang HZ, Johnston J, Keppel G, Kolomensky YG, Kowalski R, Liu R, Ma L, Ma YG, Marini L, Maruyama RH, Mayer D, Mei Y, Morganti S, Napolitano T, Nastasi M, Nikkel J, Nones C, Norman EB, Nucciotti A, Nutini I, O'Donnell T, Olmi M, Ouellet JL, Pagan S, Pagliarone CE, Pagnanini L, Pallavicini M, Pattavina L, Pavan M, Pessina G, Pettinacci V, Pira C, Pirro S, Pozzi S, Previtali E, Puiu A, Quitadamo S, Ressa A, Rosenfeld C, Sangiorgio S, Schmidt B, Scielzo ND, Sharma V, Singh V, Sisti M, Speller D, Surukuchi PT, Taffarello L, Terranova F, Tomei C, Vetter KJ, Vignati M, Wagaarachchi SL, Wang BS, Welliver B, Wilson J, Wilson K, Winslow LA, Zimmermann S, Zucchelli S. New Direct Limit on Neutrinoless Double Beta Decay Half-Life of ^{128}Te with CUORE. Phys Rev Lett 2022; 129:222501. [PMID: 36493444 DOI: 10.1103/physrevlett.129.222501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/06/2022] [Revised: 07/22/2022] [Accepted: 10/03/2022] [Indexed: 06/17/2023]
Abstract
The Cryogenic Underground Observatory for Rare Events (CUORE) at Laboratori Nazionali del Gran Sasso of INFN in Italy is an experiment searching for neutrinoless double beta (0νββ) decay. Its main goal is to investigate this decay in ^{130}Te, but its ton-scale mass and low background make CUORE sensitive to other rare processes as well. In this Letter, we present our first results on the search for 0νββ decay of ^{128}Te, the Te isotope with the second highest natural isotopic abundance. We find no evidence for this decay, and using a Bayesian analysis we set a lower limit on the ^{128}Te 0νββ decay half-life of T_{1/2}>3.6×10^{24} yr (90% CI). This represents the most stringent limit on the half-life of this isotope, improving by over a factor of 30 the previous direct search results, and exceeding those from geochemical experiments for the first time.
Collapse
Affiliation(s)
- D Q Adams
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - C Alduino
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - K Alfonso
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
| | - F T Avignone
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - O Azzolini
- INFN-Laboratori Nazionali di Legnaro, Legnaro (Padova) I-35020, Italy
| | - G Bari
- INFN-Sezione di Bologna, Bologna I-40127, Italy
| | - F Bellini
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - G Benato
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - M Beretta
- Department of Physics, University of California, Berkeley, California 94720, USA
| | - M Biassoni
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - A Branca
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - C Brofferio
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - C Bucci
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - J Camilleri
- Center for Neutrino Physics, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - A Caminata
- INFN-Sezione di Genova, Genova I-16146, Italy
| | - A Campani
- INFN-Sezione di Genova, Genova I-16146, Italy
- Dipartimento di Fisica, Università di Genova, Genova I-16146, Italy
| | - L Canonica
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - X G Cao
- Key Laboratory of Nuclear Physics and Ion-beam Application (MOE), Institute of Modern Physics, Fudan University, Shanghai 200433, China
| | - S Capelli
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - C Capelli
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - L Cappelli
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - L Cardani
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - P Carniti
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - N Casali
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - E Celi
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Gran Sasso Science Institute, L'Aquila I-67100, Italy
| | - D Chiesa
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - M Clemenza
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - S Copello
- INFN-Sezione di Genova, Genova I-16146, Italy
- Dipartimento di Fisica, Università di Genova, Genova I-16146, Italy
| | - O Cremonesi
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - R J Creswick
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - A D'Addabbo
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - I Dafinei
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - F Del Corso
- INFN-Sezione di Bologna, Bologna I-40127, Italy
| | - S Dell'Oro
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - S Di Domizio
- INFN-Sezione di Genova, Genova I-16146, Italy
- Dipartimento di Fisica, Università di Genova, Genova I-16146, Italy
| | - S Di Lorenzo
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - V Dompè
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - D Q Fang
- Key Laboratory of Nuclear Physics and Ion-beam Application (MOE), Institute of Modern Physics, Fudan University, Shanghai 200433, China
| | - G Fantini
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - M Faverzani
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - E Ferri
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - F Ferroni
- INFN-Sezione di Roma, Roma I-00185, Italy
- Gran Sasso Science Institute, L'Aquila I-67100, Italy
| | - E Fiorini
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - M A Franceschi
- INFN-Laboratori Nazionali di Frascati, Frascati (Roma) I-00044, Italy
| | - S J Freedman
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - S H Fu
- Key Laboratory of Nuclear Physics and Ion-beam Application (MOE), Institute of Modern Physics, Fudan University, Shanghai 200433, China
| | - B K Fujikawa
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - S Ghislandi
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Gran Sasso Science Institute, L'Aquila I-67100, Italy
| | - A Giachero
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - A Gianvecchio
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - L Gironi
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - A Giuliani
- Universit Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - P Gorla
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - C Gotti
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - T D Gutierrez
- Physics Department, California Polytechnic State University, San Luis Obispo, California 93407, USA
| | - K Han
- INPAC and School of Physics and Astronomy, Shanghai Jiao Tong University; Shanghai Laboratory for Particle Physics and Cosmology, Shanghai 200240, China
| | - E V Hansen
- Department of Physics, University of California, Berkeley, California 94720, USA
| | - K M Heeger
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - R G Huang
- Department of Physics, University of California, Berkeley, California 94720, USA
| | - H Z Huang
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
| | - J Johnston
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - G Keppel
- INFN-Laboratori Nazionali di Legnaro, Legnaro (Padova) I-35020, Italy
| | - Yu G Kolomensky
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - R Kowalski
- Department of Physics and Astronomy, The Johns Hopkins University, 3400 North Charles Street Baltimore, Maryland 21211, USA
| | - R Liu
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - L Ma
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
| | - Y G Ma
- Key Laboratory of Nuclear Physics and Ion-beam Application (MOE), Institute of Modern Physics, Fudan University, Shanghai 200433, China
| | - L Marini
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Gran Sasso Science Institute, L'Aquila I-67100, Italy
| | - R H Maruyama
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - D Mayer
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - Y Mei
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - S Morganti
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - T Napolitano
- INFN-Laboratori Nazionali di Frascati, Frascati (Roma) I-00044, Italy
| | - M Nastasi
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - J Nikkel
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - C Nones
- IRFU, CEA, Universit Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - E B Norman
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
- Department of Nuclear Engineering, University of California, Berkeley, California 94720, USA
| | - A Nucciotti
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - I Nutini
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - T O'Donnell
- Center for Neutrino Physics, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - M Olmi
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - J L Ouellet
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - S Pagan
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - C E Pagliarone
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Dipartimento di Ingegneria Civile e Meccanica, Università degli Studi di Cassino e del Lazio Meridionale, Cassino I-03043, Italy
| | - L Pagnanini
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - M Pallavicini
- INFN-Sezione di Genova, Genova I-16146, Italy
- Dipartimento di Fisica, Università di Genova, Genova I-16146, Italy
| | - L Pattavina
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - M Pavan
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - G Pessina
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | | | - C Pira
- INFN-Laboratori Nazionali di Legnaro, Legnaro (Padova) I-35020, Italy
| | - S Pirro
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - S Pozzi
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - E Previtali
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - A Puiu
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Gran Sasso Science Institute, L'Aquila I-67100, Italy
| | - S Quitadamo
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Gran Sasso Science Institute, L'Aquila I-67100, Italy
| | - A Ressa
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - C Rosenfeld
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - S Sangiorgio
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - B Schmidt
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - N D Scielzo
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - V Sharma
- Center for Neutrino Physics, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - V Singh
- Department of Physics, University of California, Berkeley, California 94720, USA
| | - M Sisti
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - D Speller
- Department of Physics and Astronomy, The Johns Hopkins University, 3400 North Charles Street Baltimore, Maryland 21211, USA
| | - P T Surukuchi
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | | | - F Terranova
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - C Tomei
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - K J Vetter
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - M Vignati
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - S L Wagaarachchi
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - B S Wang
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
- Department of Nuclear Engineering, University of California, Berkeley, California 94720, USA
| | - B Welliver
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - J Wilson
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - K Wilson
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - L A Winslow
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - S Zimmermann
- Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - S Zucchelli
- INFN-Sezione di Bologna, Bologna I-40127, Italy
- Dipartimento di Fisica e Astronomia, Alma Mater Studiorum-Università di Bologna, Bologna I-40127, Italy
| |
Collapse
|
2
|
Mani N, Cole AG, Phelps JR, Ardzinski A, Burns R, Chiu T, Cuconati A, Dorsey BD, Evangelista E, Fan K, Guo F, Harasym TO, Kadhim S, Kowalski R, Kultgen SG, Lee ACH, Li AH, Majeski SA, Miller A, Pasetka C, Reid SP, Rijnbrand R, Micolochick Steuer HM, Stever K, Tang S, Teng X, Wang X, Sofia MJ. Preclinical characterization of AB-506, an inhibitor of HBV replication targeting the viral core protein. Antiviral Res 2021; 197:105211. [PMID: 34826506 DOI: 10.1016/j.antiviral.2021.105211] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2021] [Revised: 11/19/2021] [Accepted: 11/22/2021] [Indexed: 02/06/2023]
Abstract
AB-506, a small-molecule inhibitor targeting the HBV core protein, inhibits viral replication in vitro (HepAD38 cells: EC50 of 0.077 μM, CC50 > 25 μM) and in vivo (HBV mouse model: ∼3.0 log10 reductions in serum HBV DNA compared to the vehicle control). Binding of AB-506 to HBV core protein accelerates capsid assembly and inhibits HBV pgRNA encapsidation. Furthermore, AB-506 blocks cccDNA establishment in HBV-infected HepG2-hNTCP-C4 cells and primary human hepatocytes, leading to inhibition of viral RNA, HBsAg, and HBeAg production (EC50 from 0.64 μM to 1.92 μM). AB-506 demonstrated activity across HBV genotypes A-H and maintains antiviral activity against nucleos(t)ide analog-resistant variants in vitro. Evaluation of AB-506 against a panel of core variants showed that T33N/Q substitutions results in >200-fold increase in EC50 values, while L30F, L37Q, and I105T substitutions showed an 8 to 20-fold increase in EC50 values in comparison to the wild-type. In vitro combinations of AB-506 with NAs or an RNAi agent were additive to moderately synergistic. AB-506 exhibits good oral bioavailability, systemic exposure, and higher liver to plasma ratios in rodents, a pharmacokinetic profile supporting clinical development for chronic hepatitis B.
Collapse
Affiliation(s)
- Nagraj Mani
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA.
| | - Andrew G Cole
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| | - Janet R Phelps
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| | - Andrzej Ardzinski
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| | - Robbin Burns
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| | - Tim Chiu
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| | - Andrea Cuconati
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| | - Bruce D Dorsey
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| | - Ellen Evangelista
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| | - Kristi Fan
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| | - Fang Guo
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| | - Troy O Harasym
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| | - Salam Kadhim
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| | - Roseann Kowalski
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| | - Steven G Kultgen
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| | - Amy C H Lee
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| | - Alice H Li
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| | - Sara A Majeski
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| | - Angela Miller
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| | - Chris Pasetka
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| | - Stephen P Reid
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| | - Rene Rijnbrand
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| | | | - Kim Stever
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| | - Sunny Tang
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| | - Xiaowei Teng
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| | - Xiaohe Wang
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| | - Michael J Sofia
- Arbutus Biopharma Inc., 701 Veterans Circle, Warminster, PA, 18974, USA
| |
Collapse
|
3
|
Jędrusek-Golińska A, Zielińska-Dawidziak M, Zielińska P, Kowalski R, Piasecka-Kwiatkowska D. Analysis of risk and consumers’ awareness regarding the gluten content in meat products on the example of frankfurter type sausages. Quality Assurance and Safety of Crops & Foods 2019. [DOI: 10.3920/qas2018.1401] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Affiliation(s)
- A. Jędrusek-Golińska
- Department of Gastronomy Science and Functional Foods, Poznań University of Life Sciences, Wojska Polskiego 31, 60-624 Poznań, Poland
| | - M. Zielińska-Dawidziak
- Department of Food Biochemistry and Analysis, Poznań University of Life Sciences, Mazowiecka 48, 60-623 Poznań, Poland
| | - P. Zielińska
- Department of Food Biochemistry and Analysis, Poznań University of Life Sciences, Mazowiecka 48, 60-623 Poznań, Poland
| | - R. Kowalski
- Department of Meat Technology, Poznań University of Life Sciences, Wojska Polskiego 31, 60-624 Poznań, Poland
| | - D. Piasecka-Kwiatkowska
- Department of Food Biochemistry and Analysis, Poznań University of Life Sciences, Mazowiecka 48, 60-623 Poznań, Poland
| |
Collapse
|
4
|
Włodarczyk-Stasiak M, Mazurek A, Jamroz J, Pankiewicz U, Kowalski R. Use of sweeteners in osmotic pretreatment before freeze-drying of pear and pineapple. Acta Alimentaria 2019. [DOI: 10.1556/066.2019.48.2.2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Affiliation(s)
- M. Włodarczyk-Stasiak
- Department of Analysis and Evaluation of Food Quality, Faculty of Food Science and Biotechnology, University of Life Sciences in Lublin, Skromna Street 8, 20-704 Lublin. Poland
| | - A. Mazurek
- Department of Analysis and Evaluation of Food Quality, Faculty of Food Science and Biotechnology, University of Life Sciences in Lublin, Skromna Street 8, 20-704 Lublin. Poland
| | - J. Jamroz
- Department of Analysis and Evaluation of Food Quality, Faculty of Food Science and Biotechnology, University of Life Sciences in Lublin, Skromna Street 8, 20-704 Lublin. Poland
| | - U. Pankiewicz
- Department of Analysis and Evaluation of Food Quality, Faculty of Food Science and Biotechnology, University of Life Sciences in Lublin, Skromna Street 8, 20-704 Lublin. Poland
| | - R. Kowalski
- Department of Analysis and Evaluation of Food Quality, Faculty of Food Science and Biotechnology, University of Life Sciences in Lublin, Skromna Street 8, 20-704 Lublin. Poland
| |
Collapse
|
5
|
Schuchardt B, Capan M, Linder A, Akesson P, Kowalski R, Miller K, Arnold R. 14 The Ability of Heparin-Binding Protein to Identify Delayed Shock in Emergency Department Sepsis Patients is Impacted by Age and Source of Infection. Ann Emerg Med 2017. [DOI: 10.1016/j.annemergmed.2017.07.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
6
|
Luitingh T, Lee M, Jones B, Koleff J, Aguero SW, Kowalski R, Cheung M, d’Udekem Y. Effectiveness of Exercise-Testing to Detect Late Hypertension in Children Following Coarctation Repair. Heart Lung Circ 2016. [DOI: 10.1016/j.hlc.2016.06.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
7
|
Mynard J, Cahoon G, Lee M, Wo N, Kowalski R, Smolich J, D’Udekem Y, Cheung M. Aortic impedance mismatching correlates with systolic and pulse pressures late after aortic coarctation repair. Heart Lung Circ 2015. [DOI: 10.1016/j.hlc.2015.06.727] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
8
|
Xu H, Huang X, Riserus U, Cederholm T, Lindholm B, Arnlov J, Carrero JJ, Leiba A, Vivante A, Bulednikov Y, Golan E, Skorecki K, Shohat T, Mjoen G, Zannad F, Jardine A, Schmieder R, Fellstrom B, Holdaas H, Zager P, Miskulin D, Gassman J, Kendrick C, Ploth D, Jhamb M, Jankowski V, Schulz A, Mischak H, Zidek W, Jankowski J, Lee YK, Cho A, Kim JK, Choi MJ, Kim SJ, Yoon JW, Koo JR, Kim HJ, Noh JW, Itano S, Satoh M, Kidokoro K, Sasaki T, Kashihara N, Koutroumpas G, Sarafidis P, Georgianos P, Karpetas A, Protogerou A, Syrganis C, Malindretos P, Raptopoulou K, Panagoutsos S, Pasadakis P, Zager P, Miskulin D, Gassman J, Kendrick C, Jhamb M, Ploth D, Vink EE, De Boer A, Verloop WL, Spiering W, Voskuil M, Vonken EJ, Hoogduin JM, Leiner T, Bots ML, Blankestijn PJ, Sarafidis PA, Karpetas AV, Georgianos PI, Bikos A, Sklavenitis-Pistofidis R, Tzimou R, Raptis V, Vakianis P, Tersi M, Liakopoulos V, Lasaridis AN, Protogerou A, Ribeiro S, Fernandes J, Garrido P, Sereno J, Vala H, Bronze Da Rocha E, Belo L, Costa E, Reis F, Santos-Silva A, Kalaitzidis R, Skapinakis P, Karathanos V, Karasavvidou D, Katatsis G, Pappas K, Hatzidakis S, Siamopoulos K, Margulis F, Sabbatiello R, Castro C, Ramallo S, Martinez M, Schiavelli R, Ganem D, Nakhoul F, Roth A, Farber E, Kim CS, Kim HY, Kang YU, Choi JS, Bae EH, Ma SK, Kim SW, Koutroumpas G, Sarafidis P, Georgianos P, Karpetas A, Protogerou A, Malindretos P, Syrganis C, Tzanis G, Panagoutsos S, Pasadakis P, Jankowski M, Kasztan M, Kowalski R, Piwkowska A, Rogacka D, Szczepa Ska-Konkel M, Angielski S, Evangelou D, Naka K, Kalaitzidis R, Lakkas L, Bechlioulis A, Gkirdis I, Nakas G, Zarzoulas F, Kotsia A, Balafa O, Tzeltzes G, Pappas K, Katsouras C, Dounousi E, Michalis L, Siamopoulos K, Maciorkowska D, Zbroch E, Koc-Zorawska E, Malyszko J, Karabay Bayazit A, Yuksekkaya I, Aynaci S, Anarat A, Nakai K, Fujii H, Ishida R, Utaka C, Awata R, Goto S, Ito J, Nishi S, Elsurer R, Afsar B, Lepar Z, Radulescu D, David C, Peride I, Niculae A, Checherita IA, Ciocalteu A, Sungur CI, Kanbay M, Siriopol D, Nistor I, Elcioglu OC, Telci O, Johnson R, Covic A, Vettoretti S, Gallazzi E, Meazza R, Gagliardi V, Villarini A, Alfieri CM, Floreani R, Messa P, Vettoretti S, Alfieri CM, Gallazzi E, Gagliardi V, Villarini A, Meazza R, Floreani R, Messa P, Kotovskaya Y, Villevalde S, Kobalava Z, Circiumaru A, Rusu E, Zilisteanu D, Atasie T, Cirstea F, Ecobici M, Voiculescu M, Rosca M, Tanase C, Baoti I, Vidjak V, Prka in I, Bulum T, Arslan E, Sarlak H, Cakar M, Demirbas S, Akhan M, Kurt O, Balta S, Yesilkaya S, Bulucu F, Chan CK, Lin YH, Wu VC, Wu KD, De Beus E, Bots ML, Van Zuilen AD, Wetzels JF, Blankestijn PJ, Mohaupt M, Straessle K, Baumann M, Raio L, Sirbek D, Nascimento MA, Mouro MG, Punaro GR, Mello MT, Tufik S, Higa EMS. HYPERTENSION. Nephrol Dial Transplant 2014. [DOI: 10.1093/ndt/gfu142] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
9
|
Blanco-Gozalo V, Blazquez-Medela A, Garcia-Sanchez O, Quiros Y, Montero M, Martinez-Salgado C, Lopez-Hernandez F, Lopez-Novoa J, Yao L, Qing Z, Hua X, Min F, Fei M, Ning W, Cantaluppi V, Figliolini F, Delena M, Beltramo S, Medica D, Tetta C, Segoloni G, Biancone L, Camussi G, Cunha JS, Ferreira VM, Naves MA, Boim MA, Zitman-Gal T, Golan E, Green J, Pasmanik-Chor M, Bernheim J, Benchetrit S, Riera M, Clotet S, Pascual J, Soler M, Nakai K, Fujii H, Kono K, Goto S, Hirata M, Shinohara M, Fukagawa M, Nishi S, Fan Q, Du S, Jiang Y, Wang L, Fang L, Radovits T, Mozes MM, Rosivall L, Kokeny G, Aoki R, Tateoka R, Sekine F, Kikuchi K, Yamashita Y, Itoh Y, Cappuccino L, Garibotto G, D'Amato E, Villaggio B, Gianiorio F, Mij M, Viazzi F, Salvidio G, Verzola D, Piwkowska A, Rogacka D, Audzeyenka I, Kasztan M, Angielski S, Jankowski M, Gaber EW, El-Attar HA, Liu J, Zhang W, He Y, Rogacka D, Piwkowska A, Audzeyenka I, Angielski S, Jankowski M, Macsai E, Takats Z, Derzbach L, Korner A, Vasarhelyi B, Huang MS, Bo H, Liu F, Fu P, Tsotakos NE, Tsilibary EC, Drossopoulou GI, Thawho N, Farid N, Peleg A, Levy A, Nakhoul N, Lenghel AR, Borza G, Catoi C, Bondor CI, Muresan A, Kacso IM, Song JS, Song JH, Ahn SH, Choi BS, Hong YA, Kim MY, Lim JH, Yang KS, Chung S, Shin SJ, Kim HW, Chang YS, Kim YS, Park CW, Takayanagi K, Hasegawa H, Shimizu T, Ikari A, Noiri C, Iwashita T, Tayama Y, Asakura J, Anzai N, Kanozawa K, Kato H, Mitarai T, Huang M, Bo H, Liu F, Fu P, Ashour RH, Fouda AEMM, Saad MA, El-Banna FM, Moustafa FA, Fouda MI, Sanchez-Nino MD, Sanz AB, Poveda J, Saleem M, Mathieson P, Ruiz-Ortega M, Selgas R, Egido J, Ortiz A, Clotet S, Soler MJ, Rebull M, Pascual J, Riera M, Marquez E, Riera M, Pascual J, Soler MJ, Asakura J, Hasegawa H, Takayanagi K, Tayama Y, Shimizu T, Iwashita T, Okazaki S, Kogure Y, Sano T, Hatano M, Kanozawa K, Kato H, Mitarai T, Kreft E, Kowalski R, Kasztan M, Jankowski M, Szczepansk-Konkel M, Fan Q, Liu X, Yang G, Jiang Y, Wang L, Osman NA, NasrAllah MM, Kamal MM, Ahmed AI, Fekih-Mrissa N, Mrad M, Baffoun A, Sayeh A, Hmida J, Gritli N, Galchinskaya V, Topchii I, Semenovykh P, Yefimova N, Zheng D, Hu D, Li X, Peng AI, Olea-Herrero N, Arenas M, Munoz-Moreno C, Moreno-Gomez-Toledano R, Gonzalez-Santander M, Arribas I, Bosch R. Diabetes - experimental models. Nephrol Dial Transplant 2013. [DOI: 10.1093/ndt/gft137] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
10
|
Kowalski R, Smolich J, Cheung M. Carotid Wave Intensity Analysis Reveals Increased Indices of Wave Reflection in Appropriate Weight for Age Ex-Preterm Infants. Heart Lung Circ 2013. [DOI: 10.1016/j.hlc.2013.05.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
11
|
Lee M, Rakhra S, Kowalski R, Cheung M, Konstantinov I, Brizard C, d’Udekem Y. Prevalence of Prehypertension After Coarctation Repair in Infancy in Patients with a Hypoplastic Arch. Heart Lung Circ 2013. [DOI: 10.1016/j.hlc.2013.05.591] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
12
|
Kowalski R, Smolich J, Cheung M. Experimental Validation of Non-invasive Central Aortic Wave Intensity Analysis Obtained with Conventional Echocardiography. Heart Lung Circ 2013. [DOI: 10.1016/j.hlc.2013.05.427] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
13
|
Kowalski R, Beare R, Koleff J, Doyle L, Smolich J, Cheung M. Early Increases in Wave Reflection in Ex-Premature Adolescents as Assessed by Wave Intensity Analysis. Heart Lung Circ 2012. [DOI: 10.1016/j.hlc.2012.05.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
14
|
Kitowski I, Kowalski R, Komosa A, Lechowski J, Grzywaczewski G, Scibior R, Pitucha G, Chrapowicki M. Diversity of total mercury concentrations in kidneys of birds from Eastern Poland. ekol 2012. [DOI: 10.4149/ekol_2012_01_12] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
|
15
|
Jankowski M, Szamocka E, Kowalski R, Angielski S, Szczepańska-Konkel M. The effects of P2X receptor agonists on renal sodium and water excretion in anaesthetized rats. Acta Physiol (Oxf) 2011; 202:193-201. [PMID: 21392268 DOI: 10.1111/j.1748-1716.2011.02276.x] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
AIM To investigate in vivo effects of P2X receptor activation on sodium and water excretion in urine. METHODS The clearance experiments were carried out in anaesthetized rats during intravenous infusion (2 μmol kg(-1) + 20 nmol (kg min)(-1) , v = 40 μL min(-1)) of P2X receptors agonists: α,β-methylene ATP (α,β-meATP) and β,γ-methylene ATP (β,γ-meATP). Cortical blood flow (CBF) was estimated by laser Doppler flux during intrarenal artery infusion of β,γ-meATP (20 nmol (kg min)(-1) , v = 2 μL min(-1)). Influence of α,β-meATP and β,γ-meATP on the activity of Na-K-ATPase was investigated in isolated proximal tubules. RESULTS Intravenous infusion of β,γ-meATP resulted in a marked, progressively increasing diuresis and this effect was accompanied by a progressive increase in the sodium excretion rate. The glomerular filtration rate was unaffected. The effects of β,γ-meATP were abolished by P2 receptor antagonist PPADS (70 nmol (kg min)(-1)). CBF increased by 16 ± 2% during renal artery infusion of β,γ-meATP. Furthermore, α,β-meATP and β,γ-meATP increased 1.5-fold lithium clearance (C(Li)). Sodium excretion, expressed as a fraction of the distal delivery (C(Na) C(Li) (-1)), increased 1.5-fold during infusion of α,β-meATP or β,γ-meATP. Both agonists at 10(-6) (M) produced a statistical significant decrement in the ouabain-sensitive ATPase activity about 16-20% and these effects were blocked in the presence of PPADS. CONCLUSION Activation of P2X receptors increased renal sodium and water excretion. Mechanistically, P2X agonists increased renal perfusion and inhibited sodium reabsorption via an Na-K-ATPase-dependent mechanism.
Collapse
Affiliation(s)
- M Jankowski
- Department of Therapy Monitoring and Pharmacogenetics, Medical University of Gdansk, Poland.
| | | | | | | | | |
Collapse
|
16
|
Goto K, Kawanabe K, Kowalski R, Baker D, Nakamura T. Bonding ability evaluation of bone cement on the cortical surface of rabbit's tibia. J Mater Sci Mater Med 2010; 21:139-146. [PMID: 19728043 DOI: 10.1007/s10856-009-3861-7] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/03/2009] [Accepted: 08/20/2009] [Indexed: 05/28/2023]
Abstract
A composite bone cement designated G2B1 that contains beta tricalcium phosphate particles was developed as a bone substitute for percutaneous transpedicular vertebroplasty. In this study, both G2B1 and commercial PMMA bone cement (CMW1) were implanted into proximal tibiae of rabbits, and their bone-bonding strengths were evaluated at 4, 8, 12 and 16 weeks after implantation. Some of the specimens were evaluated histologically using Giemsa surface staining, contact microradiography (CMR) and scanning electron microscopy (SEM). Histological findings showed that G2B1 contacted bone directly without intervening soft tissue in the specimens at each time point, while there was always a soft tissue layer between CMW1 and bone. The bone-bonding strength of G2B1 was significantly higher than that of CMW1 at each time point, and significantly increased from 4 weeks to 8 and 12 weeks, while it decreased significantly from 12 weeks to 16 weeks. Bone remodeling of the cortex under the cement was observed especially for G2B1 and presumably influenced the bone bonding strength of the cement. The results indicate that G2B1 has bioactivity, and bone bonding strength of bioactive bone cements can be estimated fairly with this experimental model in the short term.
Collapse
Affiliation(s)
- K Goto
- Department of Orthopaedic Surgery, Faculty of Medicine, Kyoto University, Kawahara-cho 54, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.
| | | | | | | | | |
Collapse
|
17
|
Kowalski R, Rodkiewicz T. Fatty acids in oil from Allium vegetable seeds. Chem Nat Compd 2009. [DOI: 10.1007/s10600-009-9331-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
18
|
Kowalski R. Chemical composition of essential oils and lipophilic extracts of Silphium integrifolium and S. trifoliatum inflorescences. Chem Nat Compd 2008. [DOI: 10.1007/s10600-008-9027-x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
19
|
Schoffski P, Höhn N, Kowalski R, Classen J, Meisner C, Fechner G, Dieckmann K, Winkler C, Bamberg M. Health-related quality of life (QoL) in patients with seminoma stage I treated with either adjuvant radiotherapy (RT) or two cycles of carboplatinum chemotherapy (CT): Results of a randomized phase III trial of the German Interdisciplinary Working Party on Testicular Cancer. J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.5050] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
5050 Background: RT and CT are efficient adjuvant therapies in seminoma stage I and were compared in this trial. Clinical results will be reported elsewhere. Secondary endpoint was to assess QoL. Materials and Methods: Pts were randomized to receive RT (5x2 Gy/wk, 26–30 Gy total dose) or carboplatinum (300–460 mg/m2, 1 h iv d 1, 29). The QLQ C30 vs. 2.0 (15 QoL dimensions) and the Testicular Tumour Questionnaire (TTQ, 16 domains) were completed at randomization (0) and 1, 4, and 12 months (m) after trial entry. QoL was compared over time within the two arms (Wilcoxon) and between treatments (Mann-Whitney) by intent-to-treat. Results: 807 pts were randomized. Questionnaire compliance was 72% at 0, 75% at 1, 69% at 4 and 70% at 12m. Sign. variation (p<0.05) in QoL over time in both treatment arms (no. of Qol domains with deterioration over time): QLQ C30: RT: m1 vs 0 9, m4 vs 0 2, m12 vs 0 0 , CT: m1 vs 0 6, m4 vs 0 3, m12 vs 0 1; TTQ: RT: m1 vs 0 4, m4 vs 0 2, m12 vs 0 3, CT: m1 vs 0 1, m4 vs 0 2, m12 vs 0 1. (¼ improvement over time): QLQ C30: RT: m1 vs 0 0, m4 vs 0 6, m12 vs 0 8, CT: m1 vs 0 2, m4 vs 0 6, m12 vs 0 10; TTQ: RT: m1 vs 0 1, m4 vs 0 2, m12 vs 0 3, CT: m1 vs 0 2, m4 vs 0 4, m12 vs 0 6. Sign. variation in QoL comparing treatment modalities: QLQ C30: Better QoL in RT: at m1 in 0, at m4 in 0 and at m12 in 0 domains, Better QoL in CT: at m1 in 11, at m4 in 2 and at m12 in 5 domains; TTQ: Better QoL in RT: at m1 in 4, at m4 in 1 and at m12 in 0 domains, Better QoL in CT: at m1 in 3, at m4 in 0 and at m12 in 2 domains. Discussion and Conclusions: Adjuvant RT has a more negative impact on self-reported QoL of seminoma pts than CT, as determined by two instruments over a period of one year. RT negatively affects more dimensions of QoL as compared to CT, especially during the early phase. Pts rapidly adapt to QoL impairment, with little change persisting at m12. Not all observed differences are clinically relevant. Potential bias and methodological limitations will be discussed. Given the presumed clinical equivalence of both modalities, pts should be aware of the more negative impact of RT on the well-being. Treatment recommendation should be based on objective outcome parameters, toxicity, logistics and QoL considerations. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- P. Schoffski
- Catholic University, Leuven, Belgium; Hannover Medical School, Hannover, Germany; St. Vincentius Clinic, Karlsruhe, Germany; University Tübingen, Tübingen, Germany; University Hospital Bonn, Bonn, Germany; Albertinen-Krankenhaus, Hamburg, Germany; University Carl Gustav Carus, Dresden, Germany; University Hospital Tübingen, Tübingen, Germany
| | - N. Höhn
- Catholic University, Leuven, Belgium; Hannover Medical School, Hannover, Germany; St. Vincentius Clinic, Karlsruhe, Germany; University Tübingen, Tübingen, Germany; University Hospital Bonn, Bonn, Germany; Albertinen-Krankenhaus, Hamburg, Germany; University Carl Gustav Carus, Dresden, Germany; University Hospital Tübingen, Tübingen, Germany
| | - R. Kowalski
- Catholic University, Leuven, Belgium; Hannover Medical School, Hannover, Germany; St. Vincentius Clinic, Karlsruhe, Germany; University Tübingen, Tübingen, Germany; University Hospital Bonn, Bonn, Germany; Albertinen-Krankenhaus, Hamburg, Germany; University Carl Gustav Carus, Dresden, Germany; University Hospital Tübingen, Tübingen, Germany
| | - J. Classen
- Catholic University, Leuven, Belgium; Hannover Medical School, Hannover, Germany; St. Vincentius Clinic, Karlsruhe, Germany; University Tübingen, Tübingen, Germany; University Hospital Bonn, Bonn, Germany; Albertinen-Krankenhaus, Hamburg, Germany; University Carl Gustav Carus, Dresden, Germany; University Hospital Tübingen, Tübingen, Germany
| | - C. Meisner
- Catholic University, Leuven, Belgium; Hannover Medical School, Hannover, Germany; St. Vincentius Clinic, Karlsruhe, Germany; University Tübingen, Tübingen, Germany; University Hospital Bonn, Bonn, Germany; Albertinen-Krankenhaus, Hamburg, Germany; University Carl Gustav Carus, Dresden, Germany; University Hospital Tübingen, Tübingen, Germany
| | - G. Fechner
- Catholic University, Leuven, Belgium; Hannover Medical School, Hannover, Germany; St. Vincentius Clinic, Karlsruhe, Germany; University Tübingen, Tübingen, Germany; University Hospital Bonn, Bonn, Germany; Albertinen-Krankenhaus, Hamburg, Germany; University Carl Gustav Carus, Dresden, Germany; University Hospital Tübingen, Tübingen, Germany
| | - K. Dieckmann
- Catholic University, Leuven, Belgium; Hannover Medical School, Hannover, Germany; St. Vincentius Clinic, Karlsruhe, Germany; University Tübingen, Tübingen, Germany; University Hospital Bonn, Bonn, Germany; Albertinen-Krankenhaus, Hamburg, Germany; University Carl Gustav Carus, Dresden, Germany; University Hospital Tübingen, Tübingen, Germany
| | - C. Winkler
- Catholic University, Leuven, Belgium; Hannover Medical School, Hannover, Germany; St. Vincentius Clinic, Karlsruhe, Germany; University Tübingen, Tübingen, Germany; University Hospital Bonn, Bonn, Germany; Albertinen-Krankenhaus, Hamburg, Germany; University Carl Gustav Carus, Dresden, Germany; University Hospital Tübingen, Tübingen, Germany
| | - M. Bamberg
- Catholic University, Leuven, Belgium; Hannover Medical School, Hannover, Germany; St. Vincentius Clinic, Karlsruhe, Germany; University Tübingen, Tübingen, Germany; University Hospital Bonn, Bonn, Germany; Albertinen-Krankenhaus, Hamburg, Germany; University Carl Gustav Carus, Dresden, Germany; University Hospital Tübingen, Tübingen, Germany
| |
Collapse
|
20
|
Neligan A, O’ Sullivan S, McCarthy A, Kinsella J, Kowalski R, McNamara B. A retrospective audit of nerve conduction studies in cases of suspected compression neuropathies of the upper limb. Clin Neurophysiol 2007. [DOI: 10.1016/j.clinph.2006.07.297] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
21
|
Northwood E, Fisher J, Kowalski R. Investigation of the friction and surface degradation of innovative chondroplasty materials against articular cartilage. Proc Inst Mech Eng H 2007; 221:263-79. [PMID: 17539582 DOI: 10.1243/09544119jeim178] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Understanding the wear of the biomaterial-cartilage interface is vital for the development of innovative chondroplasty. The aim of this study was to investigate a number of biphasic materials as potential chondroplasty biomaterials. Simple geometry friction and wear studies were conducted using bovine articular cartilage pins loaded against a range of single-phase and biphasic materials. The frictions of each biomaterial was compared within simple and protein-containing lubricants. Longer-term continuous sliding tests within a protein containing lubricant were also conducted at various loading conditions to evaluate the friction and degradation for each surface. All single-phase materials showed a steady rise in friction, which was dependent on the loss of interstitial fluid load support from the opposing cartilage pin. All biphasic materials demonstrated a marked reduction in friction when compared with the single-phase materials. It is postulated that the biphasic nature of each material allowed an element of fluid load support to be maintained by fluid rehydration and expulsion. In the longer-term study, significant differences in the articular cartilage pin (surface damage) between the positive control (stainless steel) and the negative control (articular cartilage) was found. The potential biphasic chondroplasty materials produced a reduction in articular cartilage pin damage when compared with the single-phase materials. The changes in surface topography of the cartilage pin were associated with increased levels of friction achieved during the continuous wear test. The study illustrated the importance of the biphasic properties of potential chondroplasty materials, and future work will focus on the optimization of biphasic properties as well as long-term durability, such that materials will more closely mimic the biotribology of natural articular cartilage.
Collapse
Affiliation(s)
- E Northwood
- School of Mechanical Engineering, Institute of Medical and Biological Engineering, University of Leeds, Leeds, UK.
| | | | | |
Collapse
|
22
|
Goto K, Shinzato S, Fujibayashi S, Tamura J, Kawanabe K, Hasegawa S, Kowalski R, Nakamura T. The biocompatibility and osteoconductivity of a cement containing beta-TCP for use in vertebroplasty. J Biomed Mater Res A 2006; 78:629-37. [PMID: 16788976 DOI: 10.1002/jbm.a.30793] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
A new composite bone cement designated "G2B1" was developed for percutaneous transpedicular vertebroplasty. G2B1 contains beta tricalcium phosphate particles and methylmethacrylate-methylacrylate copolymer as the powder components, and methylmethacrylate, urethane dimethacrylate, and tetrahydrofurfuryl methacrylate as the liquid components. Biocompatibility and osteoconductivity were evaluated using scanning electron microscopy, contact microradiography, and Giemsa surface staining 4, 8, 12, 26, and 52 weeks after implantation into rat tibiae. To evaluate osteoconductivity, affinity indices (%) were calculated. Scanning electron microscopy and contact microradiography revealed that bone contact with G2B1 was attained within 4 weeks (affinity index: 50.2 +/- 11.8 at 4 weeks) and at most of the margin within 26 weeks (affinity index: 87.4 +/- 7.2 at 26 weeks). Specifically, G2B1 contacted bone via a wide calcium-phosphate-rich layer, and its degradation started within 8 weeks, mainly in the marginal area. Giemsa surface staining showed that there was almost no inflammatory reaction around the G2B1. These results indicate that G2B1 is a biocompatible and osteoconductive bone cement.
Collapse
Affiliation(s)
- K Goto
- Department of Orthopaedic Surgery, Faculty of Medicine, Kyoto University, Kawahara-cho 54, Shogoin, Kyoto 606-8507, Japan.
| | | | | | | | | | | | | | | |
Collapse
|
23
|
Husain S, Raza K, McCurry K, Pilewski J, Spichty K, Woodcock J, Kowalski R, Britz J, Zeevi A. 351. J Heart Lung Transplant 2006. [DOI: 10.1016/j.healun.2005.11.364] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
24
|
Spichty K, Bentlejewski C, Girnita A, McDade K, Husain S, Pilewski J, Zaldonis D, Britz J, Kowalski R, Post D, McCurry K, Zeevi A. T cell immunity in lung transplant recipients. Hum Immunol 2005. [DOI: 10.1016/j.humimm.2005.08.197] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
25
|
Bentlejewski C, Guaspari D, Zdanowicz G, Girnita A, Britz J, Kowalski R, Glidewell J, Thai N, Zeevi A. Early recovery of T cell immunity in pancreas transplant recipients treated with Campath-1H. Hum Immunol 2005. [DOI: 10.1016/j.humimm.2005.08.186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
26
|
Kotłowska M, Kowalski R, Glogowski J, Jankowski J, Ciereszko A. Gelatinases and serine proteinase inhibitors of seminal plasma and the reproductive tract of turkey (Meleagris gallopavo). Theriogenology 2005; 63:1667-81. [PMID: 15763110 DOI: 10.1016/j.theriogenology.2004.07.020] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2004] [Revised: 07/20/2004] [Accepted: 07/24/2004] [Indexed: 11/23/2022]
Abstract
This study examined proteolytic enzymes and serine proteinase inhibitors in turkey seminal plasma with relation to their distribution within the reproductive tract and to yellow semen syndrome (YSS). Proteases of blood plasma, extracts from the reproductive tract, and seminal plasma were analyzed by gelatin zymography. We found a clear regional distribution of proteolytic enzymes in the turkey reproductive tract. Each part was characterized by a unique profile of serine proteolytic enzymes of molecular weights ranging from 29 to 88 kDa. The ductus deferens was found to be a site of very intense proteolytic activity. Two metalloproteases of 58 and 66 kDa were detected in all parts of the reproductive tract and seminal plasma. Using electrophoretic methods for detection of anti-trypsin activity, we found three serine proteinase inhibitors in turkey seminal plasma. Two inhibitors were found in the testis and epididymis and a third in the ductus deferens and seminal plasma. Blood plasma was characterized by the presence of two metalloproteinases and one serine proteinase inhibitor (of low migration rate) that were also detected in the reproductive tract. Amidase and anti-trypsin activities (expressed per gram of protein) differed for yellow and white seminal plasma. We concluded that turkey seminal plasma contains metalloproteases, serine proteinases, and serine proteinase inhibitors. The metalloproteases and one proteinase inhibitor are related to blood proteinases but the other two inhibitors and serine proteinases seem to be unique for the reproductive tract.
Collapse
Affiliation(s)
- M Kotłowska
- Department of Semen Biology, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, 10-747 Olsztyn, Tuwima 10, Poland
| | | | | | | | | |
Collapse
|
27
|
Zeevi A, Girnita A, Spichty K, Shahid H, Zaldonis D, Britz J, Kowalski R, Woodcock J, Post D, McCurry K. Measuring the impact of infection on T cell immunity in lung transplant recipients treated with a T cell depletion protocol. J Heart Lung Transplant 2005. [DOI: 10.1016/j.healun.2004.12.073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
28
|
Zeevi A, Girnita A, Spichty K, Shahid H, Zaldonis D, Britz J, Post D, Kowalski R. Measurement of immune function in lung transplant recipients using the Cylex ImmuKnow Assay. J Heart Lung Transplant 2005. [DOI: 10.1016/j.healun.2004.11.181] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
29
|
|
30
|
Zeevi A, Girnita A, Spichty K, Zaldonis D, McDade K, Iacono A, Yousem S, Britz J, Kowalski R, Woodcock J, Bentlejewski C, McCurry K. Impact of pre-transplant T cell depletion combined with tacrolimus monotherapy on the immune responses in lung transplant recipients. J Heart Lung Transplant 2004. [DOI: 10.1016/j.healun.2003.11.367] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
31
|
Abstract
Metastatic tumor to a pituitary adenoma has rarely been documented in the literature. We report a case of a 60-year-old man who presented with a history of progressive blurred vision and an incomplete homonymous hemianopsia. Magnetic resonance imaging showed a 5 cm heterogeneous mass which focally was contrast enhancing, involving the sella turcica and extending into the right cavernous sinus region. After worsening symptoms, repeat magnetic resonance imaging showed an increase in size of the lesion. Histologically, the mass consisted of a metastatic adenocarcinoma to a nonsecreting pituitary adenoma. The carcinoma stained focally positive with antibodies to carcinoembryonic antigen, cytokeratin 20, and p53 (60% of tumor cells), and did not stain with antibody to cytokeratin 7. The histologic appearance and immunohistochemical profile of the metastasis suggests a colorectal primary.
Collapse
Affiliation(s)
- C Noga
- Department of Anatomic Pathology, Cleveland Clinic Foundation, Cleveland, OH, USA
| | | | | | | | | |
Collapse
|
32
|
Kowalski R, Woodcock J, Sottong P, Britz JA. An immune-based assay for HIV disease management. Am Clin Lab 2001; 20:39-40. [PMID: 11505878] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
Abstract
Today, patients infected with HIV are monitored routinely for their levels of CD4+ T cells and viral load. Since either or both of these parameters are often discordant with the clinical course, the direct measurement of immune function to more accurately reflect clinical status is needed (Figure 3). The in vitro CMI test provides a rapid method for assessing cell-mediated immunity and is an important adjunct to the clinical management of these patients.
Collapse
Affiliation(s)
- R Kowalski
- Cylex Inc., 8980-I Old Annapolis Rd., Columbia, MD 21045, USA.
| | | | | | | |
Collapse
|
33
|
Abstract
Tissue regeneration strategies invoke cell-based therapies for effective tissue formation. Current assessment of mesenchymal stem cell (MSC) directed bone regeneration during in vivo assays is dependent on histologic determination of bone formation. It was the aim of this study to determine the relationship between bone sialoprotein (BSP) expression and osteocalcin expression with subsequent osteogenesis occurring in MSC-based implants. RT-PCR assessment of human actin, collagen type I, BSP, and osteocalcin indicated that undifferentiated cells did not express BSP or osteocalcin. Three weeks following implantation, human BSP could be identified in RNAs isolated from the retrieved implants. For every implant from which human BSP cDNA was amplified, parallel implants harvested at 6 weeks demonstrated bone formation at the histologic level. This study confirms that, in the context of the severe combined immunodeficiency disease (SCID) mouse model, culture-expanded, cryopreserved human MSCs have osteogenic potential and demonstrates that implanted cell gene expression can reveal the early onset of bone formation.
Collapse
Affiliation(s)
- L F Cooper
- 1 Dental Research Center, University of North Carolina School of Dentistry, Chapel Hill, 27559-7450, USA.
| | | | | | | | | |
Collapse
|
34
|
Schöffski P, Seeland G, Engel H, Grünwald V, Paul H, Merkle K, Kowalski R, Ganser A. Weekly administration of bendamustine: a phase I study in patients with advanced progressive solid tumours. Ann Oncol 2000; 11:729-34. [PMID: 10942063 DOI: 10.1023/a:1008309911008] [Citation(s) in RCA: 38] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND The cytotoxic agent bendamustine combines a purine-like benzimidazol and alkylating nitrogen mustard group. The clinically tolerated dose for single bolus bendamustine is 215 mg/m2, for fractionated therapy on four consecutive days 85 mg/m2. The maximum tolerated dose of a day 1 and 8 (q4w) 30 min infusion schedule was recently found to be 160 mg/m2, mouth dryness and fatigue were dose-limiting. Our current phase I trial was designed to define the recommended dose of a new weekly short infusion schedule. PATIENTS AND METHODS Patients with refractory malignant tumours qualified for the trial after written informed consent was obtained. Bendamustine was given as a 30-min i.v. infusion weekly for up to eight consecutive weeks. RESULTS Twelve patients (8 male, 4 female, median age 57.5 years, range 42-64) were enrolled in this trial. At the starting dose of 80 mg/m2, two patients had dose-limiting toxicity (fatigue grade 3, mouth dryness grade 3, fever grade 4 Common Toxicity Criteria). No dose-limiting events were observed in six patients treated at 60 mg/m2. An intermediate dose level of 70 mg/m2 was studied in three younger, less heavily pretreated patients, was well tolerated and not associated with dose-limiting events. Haematological toxicity was mild except for grade 3-4 lymphocytopenia, occurring in 11 of 12 patients. Bendamustine was found to induce long-lasting panlymphocytopenia with predominant B-cell cytotoxicity. CONCLUSIONS The maximum tolerated dose of weekly bendamustine given as a 30-min i.v. infusion is 80 mg/m2, mouth dryness, fatigue and fever are dose-limiting. The recommended dose for phase II trials is 60 mg/m2.
Collapse
Affiliation(s)
- P Schöffski
- Department of Haematology/Oncology, Hannover Medical School, Germany.
| | | | | | | | | | | | | | | |
Collapse
|
35
|
Ingham E, Green TR, Stone MH, Kowalski R, Watkins N, Fisher J. Production of TNF-alpha and bone resorbing activity by macrophages in response to different types of bone cement particles. Biomaterials 2000; 21:1005-13. [PMID: 10768752 DOI: 10.1016/s0142-9612(99)00261-6] [Citation(s) in RCA: 70] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
We have compared the capacity of clinically relevant wear debris from seven different cement types to activate macrophages to produce TNF-alpha, IL-1beta, IL-6 and bone resorbing activity in vitro. The bone cements were: CMW 1 original (PMMA only); CMW 1RO (1 microm BaSO4; 9.2%); CMW copolymer bone cement 1 (10 microm BaSO4; 10%); CMW copolymer bone cement 2 (1 microm BaSO4; 10%); Palacos R (10 microm ZrO2; 15.6%); CMW Calcium phosphate cement 20% (10 microm tri-calcium phosphate; 20%) and CMW calcium phosphate cement 30% (10 microm tri-calcium phosphate; 30%). Cement debris was produced aseptically using a simple configuration wear test. The majority of particles were in the size range 0.1-0.5 microm for each cement type. The cement particles were co-cultured with the U937 macrophage cell line at ratios of 10 and 100 microm3 particle volumes to macrophage cell numbers for 24 h. At the 10:1 ratio the particles had no effect on the cells. At the 100:1 ratio, the major cytokine produced was TNF-alpha and there were no statistical differences between the different types of cement debris. The bone resorption activity of the co-culture supernatants was significantly greater than the control (U937 cells without particles) for particles of CMW 1RO, CMW copolymer bone cement 1, CMW copolymer bone cement 2 and Palacos R (P < 0.05, ANOVA). However there were no statistical differences between the levels of bone resoprtion evoked by these four cement types. The CMW1 original and CMW calcium phosphate containing cements failed to induce the macrophages to elaborate bone resorption activity at the 100:1 ratio. These data suggest that the addition of radio-opaque additives to bone cement may increase the capacity of the debris to induce osteolysis.
Collapse
Affiliation(s)
- E Ingham
- Department of Microbiology, University of Leeds, UK.
| | | | | | | | | | | |
Collapse
|
36
|
Abstract
We analyze coherent two-color photoassociation of a Bose-Einstein condensate, focusing on stimulated Raman adiabatic passage (STIRAP) in free-bound-bound transitions from atoms to molecules. This problem raises an interest because STIRAP has been predicted to be absent in the nondegenerate case [Javanainen and Mackie, Phys. Rev. A 58, R789 (1998)]. Nevertheless, we find that Bose stimulation enhances the free-bound dipole matrix element for an atomic condensate, and photoassociative STIRAP turns out to be a viable mechanism for converting an atomic condensate to a molecular condensate with near-unit efficiency.
Collapse
Affiliation(s)
- M Mackie
- Department of Physics, University of Connecticut, Storrs, Connecticut 06269-3046, USA
| | | | | |
Collapse
|
37
|
Schöffski P, Hagedorn T, Grünwald V, Paul H, Merkle K, Kowalski R, Ganser A. Repeated administration of short infusions of bendamustine: a phase I study in patients with advanced progressive solid tumours. J Cancer Res Clin Oncol 2000; 126:41-7. [PMID: 10641748 DOI: 10.1007/pl00008463] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
PURPOSE The cytotoxic agent bendamustine combines a purine-like benzimidazol and bifunctionally alkylating nitrogen mustard group. The drug has clinical antitumour activity in lymphoma, myeloma and breast cancer. In earlier dose-finding studies, the clinically tolerated dose for single-bolus bendamustine was 215 mg/m2; for fractionated therapy on 4 consecutive days it was 85 mg/m2. Anticholinergic symptoms, myelosuppression and cardiac dysrhythmia were dose-limiting. Our trial was designed to define the maximum tolerated dose of a short infusion schedule and to establish a recommended dose for ongoing and future clinical studies. METHODS Patients with refractory malignant tumours qualified for the trial after written informed consent had been obtained. Bendamustine was given as a 30-min iv. infusion on days 1 and 8 of a 4 week cycle, with a starting dose of 100 mg/m2 and an increment per group of 20 mg/m2. RESULTS Nineteen patients (13 male, 6 female; median age 57 years, range 37-74 years) were treated for one to two cycles with up to 180 mg/m2 bendamustine. At 160 mg/m2, fatigue grade 3 (NCI Common Toxicity Criteria) and dryness of the mouth grade 3 occurred in 2 patients, diarrhoea grade 3 in 1 patient; another patient with a history of myocardial infarction and arrhythmia developed a reversible total atrioventricular block after the first administration of 160 mg/m2 bendamustine. Other events, such as nausea/vomiting, loss of appetite, fever or chills, were not dose-limiting. Haematological toxicity was mild, except for sudden and long-lasting grade 3-4 lymphocytopenia, which occurred in all treatment cycles. Opportunistic infections were not observed. CONCLUSIONS The maximum tolerated dose of a days-1 and -8 schedule of bendamustine, given as a 30-min i.v. infusion, is 160 mg/ m2; mouth dryness and fatigue are dose-limiting. The recommended dose for future trials is 140 mg/m2.
Collapse
Affiliation(s)
- P Schöffski
- Department of Haematology/Oncology, Hannover Medical School, Germany
| | | | | | | | | | | | | |
Collapse
|
38
|
Schöffski P, Hagedorn T, Grünwald V, Paul H, Merkle K, Kowalski R, Ganser A. Phase I-study of bendamustine-HCI in patients with solid tumors. Eur J Cancer 1999. [DOI: 10.1016/s0959-8049(99)81599-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
39
|
Abstract
This article discusses the controversial use of restraints with a persistently violent adolescent on a child and adolescent psychiatry unit. The authors present an individualized program that used a series of ambulatory restraints on a long-term basis and prophylactically to contain the aggression of a psychotic girl. Clozapine was used concomitantly to control her psychosis. The prophylactic use of mechanical restraints allowed this teenager to be integrated into the milieu and to receive multiple treatments that the standard protocol precluded. This case underscores the difficulties in managing aggression when youths do not respond to standard protocols and do not conform to our assumptions about the least restrictive alternative. It is concluded that prophylactic mechanical restraint provided the least restrictive alternative to personal freedom for this teenager and had therapeutic benefit.
Collapse
Affiliation(s)
- B Troutman
- Division of Child Psychiatry, University of Iowa, Iowa City 52242-1057, USA
| | | | | | | | | |
Collapse
|
40
|
McCloskey TW, Oyaizu N, Bakshi S, Kowalski R, Kohn N, Pahwa S. CD95 expression and apoptosis during pediatric HIV infection: early upregulation of CD95 expression. Clin Immunol Immunopathol 1998; 87:33-41. [PMID: 9576008 DOI: 10.1006/clin.1997.4496] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Pediatric HIV infection is characterized by a progressive decline in CD4 T lymphocytes and faster disease progression than is typically seen in adults. Apoptosis, possibly mediated through the CD95 antigen, has been proposed as a mechanism for cell loss which eventually leads to immune dysfunction. In this study of peripheral blood lymphocytes from HIV-infected children, classified according to CDC immunologic categories, we found that the percentage of CD4 and CD8 T cells expressing CD95 and the percentage of lymphocytes undergoing apoptosis were increased in children with HIV infection and were greater in children from immunologic Category III as compared to those in Category I. Most striking was our observation that an increased percentage of CD95-positive cells appeared as early as 3 months of age, at a time when these children did not have elevated levels of apoptosis. These data demonstrate early upregulation of CD95 expression in HIV-infected infants, an abberation which may have profound implications for the pathogenesis of perinatally acquired HIV disease.
Collapse
Affiliation(s)
- T W McCloskey
- Department of Pediatrics, North Shore University Hospital-New York University School of Medicine, Manhasset 11030, USA
| | | | | | | | | | | |
Collapse
|
41
|
Booth MC, Hatter KL, Miller D, Davis J, Kowalski R, Parke DW, Chodosh J, Jett BD, Callegan MC, Penland R, Gilmore MS. Molecular epidemiology of Staphylococcus aureus and Enterococcus faecalis in endophthalmitis. Infect Immun 1998; 66:356-60. [PMID: 9423880 PMCID: PMC107899 DOI: 10.1128/iai.66.1.356-360.1998] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
Genomic DNA fingerprint analysis was performed on 39 Staphylococcus aureus and 28 Enterococcus faecalis endophthalmitis isolates collected from multiple clinical centers. Among 21 S. aureus genomic DNA fingerprint patterns identified, five clonotypes were recovered from multiple unrelated patients and accounted for 58.9% (23 of 39) of the isolates analyzed. Compared with strains having unique genomic DNA fingerprint patterns, the S. aureus clonotypes occurring more than once were more likely to result in visual acuities of 20/200 or worse (P = 0.036 [chi2 test]). In contrast to the S. aureus isolates, the E. faecalis endophthalmitis isolates were a clonally diverse population, enriched for the expression of a known toxin, cytolysin, which is plasmid encoded.
Collapse
Affiliation(s)
- M C Booth
- Department of Ophthalmology and Dean A. McGee Eye Institute, Molecular Pathogenesis of Eye Infection Research Center, University of Oklahoma Health Sciences Center, Oklahoma City 73104, USA.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Abstract
This study investigated the moderating effects of perceived prepubertal social support on the relationship between prepubertal childhood physical abuse and child abuse potential as well as on the relationship between a childhood history of abuse and conflict and depth in adult relationships. Three hundred and sixty-nine undergraduate men and women were classified as abused or nonabused based on their responses to the Childhood History Questionnaire. Multiple regression analyses revealed interactions of social support and a childhood history of physical abuse on both the potential to abuse and the quality of participants' relationships with their parents. Differences between abused and nonabused individuals were obtained only under conditions of low perceived social support. When social support was perceived to be high, abused and nonabused individuals did not differ in the potential to abuse or in the ratings of the depth of their relationships with parents. Implications of these findings for the intergenerational transmission of abuse are discussed.
Collapse
Affiliation(s)
- C G Litty
- Department of Psychology, Western Carolina University, Cullowhee, NC 28723, USA
| | | | | |
Collapse
|
43
|
Paul MO, Tetali S, Lesser ML, Abrams EJ, Wang XP, Kowalski R, Bamji M, Napolitano B, Gulick L, Bakshi S. Laboratory diagnosis of infection status in infants perinatally exposed to human immunodeficiency virus type 1. J Infect Dis 1996; 173:68-76. [PMID: 8537684 DOI: 10.1093/infdis/173.1.68] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
Abstract
Accurate and timely diagnosis of infection status in infants born to women infected with human immunodeficiency virus (HIV) is of paramount importance. The comparative accuracy of five diagnostic decision rules was evaluated in 208 HIV-exposed infants (32 infected, 176 uninfected) based on laboratory testing during the first 6 months of life. Diagnostic rules A and B, which required single blood samples analyzed by culture and polymerase chain reaction (PCR) (rule A) or culture, PCR, and p24 antigen detection (rule B) were more prone to incorrect diagnoses than were rules requiring 2 blood samples analyzed by a single assay (rule C) or combinations of culture and PCR (rules D and E). Rule D, which used PCR as the initial test, established the most useful algorithm: a positive PCR result followed by a positive culture in the second sample confirmed infected status, while two consecutive negative PCR results reconfirmed as negative at 6 months of age established uninfected status.
Collapse
Affiliation(s)
- M O Paul
- Department of Pediatrics, North Shore University Hospital-Cornell University Medical College, Manhasset, NY 11030, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Abstract
Historically lymphoepithelioma was a term used to describe an undifferentiated mucosal carcinoma with a lymphocytic component arising only from the nasopharynx, although recently, lymphoepithelioma-like carcinoma has been found to occur as a primary tumor of the lung. Thus far, five patients have been documented as having this rare anatomical presentation. The patient that is being presented is the latest case of lymphoepithelioma-like carcinoma of the lung and will be compared clinically and histologically with the other four cases. The case is presented in order to discuss optimal methods of diagnoses and treatment for this condition.
Collapse
Affiliation(s)
- B Miller
- Department of Surgery, University of Illinois, College of Medicine, Peoria 61603
| | | | | | | | | | | |
Collapse
|
45
|
Gordon YJ, Araullo-Cruz T, Romanowski E, Myers B, Santora D, Lin M, Kowalski R. Replication of ocular isolates of human adenovirus is serotype-dependent in rabbit corneal organ culture. Curr Eye Res 1991; 10:267-71. [PMID: 2044392 DOI: 10.3109/02713689109003449] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
The goal of the present in vitro study was to determine the ability of unadapted human adenoviral ocular isolates to replicate in the rabbit cornea. Rabbit corneas grown in organ culture (24 well plate) were inoculated topically with 50 microliters (5 x 10(5) pfu) of different ocular adenoviral serotypes (ATCC and clinical isolates). Control wells (no cornea present) were inoculated in a similar fashion. Viral replication was determined by serial aliquots titrated on A549 cells. We demonstrated sustained viral replication over time of all isolates (100%) of Ad1, 2, 5, 6, 8, 9, 11 and 37 tested. No isolates (0%) of Ad3, 7A, 19, and 4 demonstrated replication in our model. Peak titers varied among successful serotypes from 10(2) pfu/ml (Ad11) to 10(5) PFU/ml (Ad5), and among different isolates of a given serotype. We conclude that the ability of unadapted human Ad serotypes to replicate in rabbit corneas was serotype-dependent, and that subgroup C (Ad1, 2, 5, and 6) appeared to be the most successful subgroup.
Collapse
Affiliation(s)
- Y J Gordon
- Charles T. Campbell Laboratory, University of Pittsburgh, PA
| | | | | | | | | | | | | |
Collapse
|
46
|
Abstract
The evaluation of patients with ureteral calculi in the emergency department has historically included urinalysis (UA) and intravenous pyelograms (IVP). This retrospective study was done to determine if a statistically significant relationship existed between the degree of calculus-related ureteral obstruction, proven by IVP, and the presence or absence of microscopic hematuria. Urine red blood cells were recorded as less than 3 rbc/hpf (negative) or greater than or equal to 3 rbc/hpf (positive). IVPs were recorded as nonsevere or severe. IVP criteria were based on the presence or absence of extravasation, greater than 2-hour ureteral filling times, and a numerical scoring system of 1 to 4 for ureteral or calyceal dilatation and nephrogenic effect. Eighty-nine men (72%) had non-severe obstructions and 34 (28%) had severe obstructions. Twenty-five women (68%) had nonsevere obstructions and 12 (32%) had severe obstructions. Of the 28 patients with normal UAs, 11 had severe ureteral obstructions and 17 had nonsevere ureteral obstructions. There were no statistically significant differences between the presence or absence of significant microscopic hematuria and the presence or absence of severe ureteral obstruction. Microscopic hematuria is neither sensitive nor specific in determining the degree of calculus-related ureteral obstruction.
Collapse
Affiliation(s)
- D P Stewart
- Michigan State School of Medicine, Kalamazoo
| | | | | | | |
Collapse
|
47
|
Kowalski R, Davies SE, Hawkes C. Metal composition as a natural marker in anthomyiid flyDelia radicum (L.). J Chem Ecol 1989; 15:1231-9. [DOI: 10.1007/bf01014825] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/1988] [Accepted: 06/01/1988] [Indexed: 11/25/2022]
|
48
|
Abstract
In the prehospital management of trauma, a variety of devices are used for immobilization of the spinal column during extrication and transport. Two of these commonly used immobilizers, the Zee Extrication Device and the long spinal board, use crisscrossing straps over the thorax to affix the patient to the device. Our study was designed to determine if these two devices alter pulmonary function in the healthy, nonsmoking man. We took 15 healthy, nonsmoking male volunteers and tested four pulmonary function parameters: forced vital capacity (FVC), forced expiratory volume in one second (FEV1), the ratio FEV1:FVC, and forced mid-expiratory flow (FEF 25%-75%). A Breon spirometer was used to test these functions both before and after the volunteers were strapped into the two devices. Three separate trials were given for each parameter and the best scores were used for data computation. Strap tension was controlled by placing a sphygmomanometer beneath each strap and adding tension to produce 10 mm Hg pressure. We found a significant difference (P less than .05) between prestrapping and poststrapping values for three of the four functions tested using the long spinal board: FVC (P = .0079), FEV1 (P = .0001), and FEF 25%-75% (P = .0252). Similarly significant differences were found for three of the four parameters using the Zee Extrication Device: FVC (P = .004), FEV1 (P = .0022), and FEF 25%-75% (P = .008). These differences reflect a marked pulmonary restrictive effect. The ratio FEV1:FVC can be normal or even slightly elevated with restrictive airway disease due to proportional reductions of each parameter. Correspondingly, we found no significant difference between prestrapping and poststrapping FEV1:FVC values (P greater than .05).(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- D Bauer
- Department of Emergency Medicine, William Beaumont Hospital, Royal Oak, Michigan 48072
| | | |
Collapse
|
49
|
Stueven H, Troiano P, Thompson B, Mateer JR, Kastenson EH, Tonsfeldt D, Hargarten K, Kowalski R, Aprahamian C, Darin J. Bystander/first responder CPR: ten years experience in a paramedic system. Ann Emerg Med 1986; 15:707-10. [PMID: 3706861 DOI: 10.1016/s0196-0644(86)80430-9] [Citation(s) in RCA: 76] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
The effectiveness of bystander CPR recently has been challenged. We undertook a ten-year retrospective review of our prehospital experience with witnessed cardiorespiratory arrest to ascertain save rates in patients receiving and not receiving CPR before paramedic advanced life support (ALS). Traumatic and poisoning arrests and children less than 18 years old were excluded. A total of 1,905 patients presenting to a paramedic system from November 1, 1973, to October 31, 1983, were bystander-witnessed arrests and attempted paramedic resuscitations. Four hundred five paramedic-witnessed arrests were excluded. One hundred eighty-two of 1,248 (14.6%) who had CPR initiated before paramedic ALS arrival were saves, compared to 38 of 252 (15%) who had no CPR initiated until paramedic arrival (P = NS). A save was defined as a patient discharged from the hospital. The respective save rates for coarse ventricular fibrillation were 148 of 628 (23.6%) (CPR before paramedic arrival) vs 35 of 151 (CPR delayed until paramedic arrival) (23.2%); electromechanical dissociation (EMD), 11 of 209 (5.3%) vs 0 of 38; asystole, 19 of 401 (4.7%) vs 3 of 61 (4.9%); and ventricular tachycardia, four of ten (40%) vs 0 of two. In this prehospital system, bystander/first responder CPR was found not to improve hospital discharge rates except in patients with initially documented rhythm of EMD.
Collapse
|
50
|
Stueven HA, Troiano P, Thompson B, Mateer JR, Kastenson EH, Tonsfeldt D, Hargarten K, Kowalski R, Aprahamian C, Darin J. Bystander/first responder CPR: Ten-year experience in a paramedic system. Ann Emerg Med 1985. [DOI: 10.1016/s0196-0644(85)80400-5] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|